MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
基本信息
- 批准号:7118627
- 负责人:
- 金额:$ 34.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:DNA methylationadipocytesbiological signal transductionbone development disordercell differentiationcell lineclinical researchembryonic stem cellfamily geneticsgene expressiongene mutationgene targetinggenetic disordergenetic polymorphismgenetic regulationgenetically modified animalsguanine nucleotide binding proteinhuman subjectlaboratory mousemessenger RNAnucleic acid sequenceosteoblastspluripotent stem cellspolymerase chain reactionsite directed mutagenesis
项目摘要
DESCRIPTION (provided by applicant): Genetic disorders of osteogenesis provide valuable insight into the regulation of bone formation. Progressive osseous heteroplasia (POH) is a rare and disabling genetic disorder in which the body produces bone in skin, fat and skeletal muscle. Gene mutations in POH patients inactivate one of the two copies of the GNAS gene and alter the fate of cells to cause bone formation in inappropriate locations (heterotopic ossification). GNAS encodes the G(s)alpha protein, which couples signaling via cell surface receptors to intracellular second messengers, however the specific effects of these mutations on bone cell differentiation are unknown. Ectopic bone formation in POH patients often arises within subcutaneous fat, suggesting a close, perhaps reciprocal, relationship between bone and fat cell differentiation. In addition to continuing investigations of GNAS inheritance and expression in POH, a primary goal of this proposal is to examine the effects of heterozygous inactivating GNAS mutations on bone (osteoblast) and fat (adipocyte) cell differentiation. We hypothesize that: (1) Heterozygous inactivating mutation of the GNAS gene alters cellular signaling that directs osteoblast and/or adipocyte differentiation, and (2) The complex phenotypic consequences of inactivating GNAS mutations are influenced by maternal/paternal inheritance of GNAS. The following Specific Aims will be conducted: 1. Investigate the parental origin of the GNAS allele that carries GNAS mutations in POH patients. 2. Examine POH genomic DNA for methylation characteristic of imprinting at the GNAS locus. 3. Examine the differential expression of GNAS mRNAs during osteoblast and adipocyte differentiation. 4. Examine the effects of heterozygous GNAS gene inactivation on osteoblast and adipocyte differentiation. 5. Investigate the effects of an inactive GNAS gene on expression of specific GNAS transcripts during osteoblast and adipocyte differentiation. The overall goal of this project is to characterize the role of the GNAS gene in the regulation of bone cell differentiation. The studies described in this proposal will provide the foundation to examine the specific pathways through which GNAS regulates osteogenesis. These investigations will provide important information for developing diagnostic and treatment strategies for a wide range of disorders of bone such as POH and more common conditions.
描述(由申请人提供):骨生成的遗传性疾病为骨形成的调节提供了有价值的见解。进行性骨异型增生(POH)是一种罕见的致残性遗传疾病,其中身体在皮肤,脂肪和骨骼肌中产生骨。POH患者的基因突变使GNAS基因的两个拷贝之一丢失,并改变细胞的命运,导致骨形成在不适当的位置(异位骨化)。GNAS编码G(s)α蛋白,其通过细胞表面受体将信号传导偶联到细胞内第二信使,然而这些突变对骨细胞分化的具体影响尚不清楚。POH患者的异位骨形成通常发生在皮下脂肪中,这表明骨和脂肪细胞分化之间存在密切的关系,可能是相互的关系。除了继续研究POH中GNAS的遗传和表达外,该提案的主要目标是研究杂合失活GNAS突变对骨(成骨细胞)和脂肪(脂肪细胞)细胞分化的影响。我们假设:(1)GNAS基因的杂合失活突变改变了指导成骨细胞和/或脂肪细胞分化的细胞信号传导,以及(2)GNAS失活突变的复杂表型结果受GNAS的母系/父系遗传的影响。具体目标如下:1。调查POH患者携带GNAS突变的GNAS等位基因的父母来源。2.检查POH基因组DNA在GNAS基因座处印迹的甲基化特征。3.检查成骨细胞和脂肪细胞分化过程中GNAS mRNA的差异表达。4.检测杂合GNAS基因失活对成骨细胞和脂肪细胞分化的影响。5.研究成骨细胞和脂肪细胞分化过程中,失活的GNAS基因对特定GNAS转录物表达的影响。该项目的总体目标是表征GNAS基因在骨细胞分化调控中的作用。本提案中描述的研究将为检查GNAS调节骨生成的特定途径提供基础。这些调查将提供重要的信息,制定诊断和治疗策略的广泛的骨疾病,如POH和更常见的条件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EILEEN M SHORE其他文献
EILEEN M SHORE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EILEEN M SHORE', 18)}}的其他基金
Advances in Mineral Metabolism (AIMM) Annual Meeting
矿物质代谢进展 (AIMM) 年会
- 批准号:
10752804 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
Avances in Mineral Metabolism (AIMM) meeting
矿物质代谢进展 (AIMM) 会议
- 批准号:
10614914 - 财政年份:2020
- 资助金额:
$ 34.05万 - 项目类别:
Advances in Mineral Metabolism(AIMM) 2019 annual meeting
矿物质代谢进展(AIMM)2019年会
- 批准号:
9760686 - 财政年份:2019
- 资助金额:
$ 34.05万 - 项目类别:
Advances in Mineral Metabolism (AIMM) 2016 annual meeting
矿物质代谢进展 (AIMM) 2016 年会
- 批准号:
9335546 - 财政年份:2017
- 资助金额:
$ 34.05万 - 项目类别:
Advances in Mineral Metabolism (AIMM) 2015 annual meeting
矿物质代谢进展 (AIMM) 2015 年会
- 批准号:
8911461 - 财政年份:2015
- 资助金额:
$ 34.05万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
7924441 - 财政年份:2009
- 资助金额:
$ 34.05万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
6090796 - 财政年份:2000
- 资助金额:
$ 34.05万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
7485034 - 财政年份:2000
- 资助金额:
$ 34.05万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
7268813 - 财政年份:2000
- 资助金额:
$ 34.05万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
6917991 - 财政年份:2000
- 资助金额:
$ 34.05万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
- 批准号:
23K16058 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Renin-Angiotensin System in Air Pollution-Mediated Exacerbation of Obesity.
空气污染介导的肥胖加剧中的肾素-血管紧张素系统。
- 批准号:
10654124 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
Defining the role of mechanoresponsive adipocyte-to-fibroblast transition in wound fibrosis.
定义机械反应性脂肪细胞向成纤维细胞转变在伤口纤维化中的作用。
- 批准号:
10654464 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
METABOLIC IMPACTS OF TYPE II INTERFERON SIGNALS IN OBESITY
II 型干扰素信号对肥胖的代谢影响
- 批准号:
10775353 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
- 批准号:
10733720 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
Impact of Exposure to Perfluoroalkyl Substances on Weight Loss: A Pilot Study of Hispanic Children with Overweight/Obesity Participating in a Community-based Weight Loss Intervention Program
接触全氟烷基物质对减肥的影响:对参加社区减肥干预计划的超重/肥胖西班牙裔儿童的初步研究
- 批准号:
10724050 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
Role of SIK3 in PKA/mTORC1 regulation of adipose browning
SIK3 在 PKA/mTORC1 调节脂肪褐变中的作用
- 批准号:
10736962 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
Engineered hybrid aging model for disease progression
用于疾病进展的工程混合衰老模型
- 批准号:
10608767 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation
组织衰老和年龄相关的代谢功能障碍:免疫细胞介导的炎症的作用
- 批准号:
10585818 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
- 批准号:
10605981 - 财政年份:2023
- 资助金额:
$ 34.05万 - 项目类别:














{{item.name}}会员




